Document is current
Any future updates will be listed below
-
Authors
Geldhof, Vincent
de Rooij, Laura P. M. H.
Sokol, Liliana
Amersfoort, Jacob
De Schepper, Maxim https://orcid.org/0000-0001-9829-8535
Rohlenova, Katerina https://orcid.org/0000-0003-3964-8472
Hoste, Griet
Vanderstichele, Adriaan
Delsupehe, Anne-Marie
Isnaldi, Edoardo https://orcid.org/0000-0002-1055-7254
Dai, Naima
Taverna, Federico
Khan, Shawez https://orcid.org/0000-0003-1682-4824
Truong, Anh-Co K.
Teuwen, Laure-Anne
Richard, François https://orcid.org/0000-0003-4353-3619
Treps, Lucas
Smeets, Ann https://orcid.org/0000-0002-5091-6602
Nevelsteen, Ines
Weynand, Birgit https://orcid.org/0000-0003-4246-6303
Vinckier, Stefan
Schoonjans, Luc https://orcid.org/0000-0002-8291-6666
Kalucka, Joanna https://orcid.org/0000-0003-4887-7672
Desmedt, Christine https://orcid.org/0000-0002-5223-5579
Neven, Patrick
Mazzone, Massimiliano
Floris, Giuseppe https://orcid.org/0000-0003-2391-5425
Punie, Kevin https://orcid.org/0000-0002-1162-7963
Dewerchin, Mieke https://orcid.org/0000-0002-0382-9346
Eelen, Guy
Wildiers, Hans https://orcid.org/0000-0001-8990-7837
Li, Xuri https://orcid.org/0000-0002-8277-0767
Luo, Yonglun https://orcid.org/0000-0002-0007-7759
Carmeliet, Peter https://orcid.org/0000-0001-7961-1821
- License Information
-
More Information
Article History
Received: 25 January 2021
Accepted: 30 August 2022
First Online: 20 September 2022
Competing interests
: K.P. is a speaker and/or consultant for Astra Zeneca, Eli Lilly, Exact Sciences, Focus Patient, Gilead Sciences, Medscape/Genomic Health, MSD, Novartis, Pfizer, Roche, Seagen (outside the submitted work), and has received research/travel support from Sanofi, MSD, Astra Zeneca, Novartis, Pfizer, PharmaMar, Roche (outside the submitted work). The other authors declare no competing interests.
